Tuberculosis and Respiratory Diseases

Search

Page Path

Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea: Kyung-Wook Jo, Young Soon Yoon, Hyung Woo Kim, Joong-Yub Kim, Young Ae Kang; Tuberc Respir Dis. 2025;88(1):56-68. Published online October 4, 2024; DOI: https://doi.org/10.4046/trd.2024.0122; Full text PubReader ePub PDF

High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis: Nakwon Kwak, Joong-Yub Kim, Hyung-Jun Kim, Byoung-Soo Kwon, Jae Ho Lee, Jeongha Mok, Yong-Soo Kwon, Young Ae Kang, Youngmok Park, Ji Yeon Lee, Doosoo Jeon, Jung-Kyu Lee, Jeong Seong Yang, Jake Whang, Kyung Jong Kim, Young Ran Kim, Minkyoung Cheon, Jiwon Park, Seokyung Hahn, Jae-Joon Yim; Tuberc Respir Dis. 2025;88(1):170-180. Published online September 27, 2024; DOI: https://doi.org/10.4046/trd.2024.0099; Full text PubReader ePub PDF

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

MOST VIEWED MOST CITED

21,129	Clonal Hematopoiesis of Indeterminate Potential Is Associated with Current Smoking Status and History of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease
7,802	Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis
3,602	Regenerative Capacity of Alveolar Type 2 Cells Is Proportionally Reduced Following Disease Progression in Idiopathic Pulmonary Fibrosis-Derived Organoid Cultures
2,682	Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
3,409	Tuberculosis Notification and Incidence: Republic of Korea, 2022

Cited By 25	Tuberculosis: Republic of Korea, 2021
Cited By 13	Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model
Cited By 12	The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
Cited By 6	New Targeted Therapy for Non-Small Cell Lung Cancer
Cited By 6	Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org